Macrogenics (MGNX) Inventory Average (2021 - 2026)
Macrogenics (MGNX) posted quarterly Inventory Average of $8.7 million for Q1 2026, up 4.19% quarter-over-quarter from $8.4 million in Q4 2025.
Macrogenics (MGNX) Inventory Average (2021 - 2026) Analysis & Trends
Macrogenics (MGNX) has reported Inventory Average for 6 consecutive years, with $8.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average changed N/A year-over-year to $8.7 million; the TTM figure through Mar 2026 stood at $8.7 million (changed N/A YoY), while the FY2023 annual figure was $1.3 million, down 54.24% from the prior year.
- Inventory Average rose to $8.7 million in Q1 2026 per MGNX's latest filing, from $8.4 million in the prior quarter.
- Across five years, Inventory Average topped out at $9.4 million in Q2 2025 and bottomed at $1.1 million in Q4 2023.
- Historically, Inventory Average has averaged $3.8 million across 5 years, with a median of $2.0 million in 2022.
- Annual changes were most pronounced in 2022 — Inventory Average slumped 69.68% — and 2025, when it surged 691.37%.
- Macrogenics' Inventory Average stood at $1.3 million in 2022, then retreated by 9.85% to $1.1 million in 2023, then soared by 90.6% to $2.2 million in 2024, then soared by 283.34% to $8.4 million in 2025, then increased by 4.19% to $8.7 million in 2026.
- Business Quant data shows MGNX's Inventory Average at $8.7 million in Q1 2026, $8.4 million in Q4 2025, and $9.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Macrogenics | 268.22 Mn | 201.71 Mn | - | 8.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.71 Mn |
| Dec 31, 2025 | 8.36 Mn |
| Sep 30, 2025 | 9.05 Mn |
| Jun 30, 2025 | 9.35 Mn |
| Sep 30, 2024 | 2.18 Mn |
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 1.43 Mn |
| Mar 31, 2023 | 1.43 Mn |
| Dec 31, 2022 | 1.27 Mn |
| Sep 30, 2022 | 2.02 Mn |
| Jun 30, 2022 | 3.77 Mn |
| Mar 31, 2022 | 4.49 Mn |
| Dec 31, 2021 | 4.18 Mn |
| Sep 30, 2021 | 5.23 Mn |
| Jun 30, 2021 | 6.32 Mn |